세계의 골내 주입 기기 시장 규모, 점유율 및 동향 분석 보고서 - 장치 유형별, 최종 사용자별, 지역별 전망 및 예측(2024-2031년)

Global Intraosseous Infusion Devices Market Size, Share & Trends Analysis Report By Devices Type (Manual IO Needles, Battery Powered Driver and Impact Driven Devices), By End User, By Regional Outlook and Forecast, 2024 - 2031

US $ 3,600 ￦ 5,086,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,320 ￦ 6,104,000

PDF (Multi User License)

PDF 보고서를 동일 기업의 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,048 ￦ 8,545,000

PDF (Corporate User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy & Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

골내 주입 기기 시장 규모는 예측 기간 동안 5.9%의 연평균 복합 성장률(CAGR)로 성장하여 2031년까지 14억 달러에 달할 것으로 예상됩니다.

또한, 코로나19 팬데믹은 의료 시스템에 전례 없는 부담을 안겨주었고, 이러한 장비와 같은 응급 의료 장비에 대한 수요가 급증했습니다. 또한, 코로나19 팬데믹은 의료 시스템이 전통적인 병원 환경 밖에서 코로나19 환자를 관리해야 하는 과제에 적응하면서 병원 전 진료 및 야외 진료로의 전환을 촉진했습니다. 이러한 장비는 고급 의료 시설에 대한 접근이 제한될 수 있는 지역 사회 환경, 야전 병원, 임시 치료 센터, 집단 예방 접종 현장에서 최전선에서 치료를 제공하는 응급 의료 서비스(EMS) 요원, 군 의료진, 구급대원에게 필수적인 도구가 되었습니다. 따라서 코로나19 팬데믹은 시장에 긍정적인 영향을 미쳤습니다.

그러나, 이러한 장비의 조달에 필요한 초기 투자비용이 높을 수 있으며, 이는 예산이 부족한 의료기관의 도입 장벽으로 작용할 수 있습니다. 또한 초기 조달 및 교육 외에도 지속적인 유지 보수 및 소모품 교체는 이러한 장비와 관련된 정기적 인 비용입니다. 따라서 이러한 측면은 시장 침체로 이어질 수 있습니다.

목차

제1장 시장 범위와 조사 방법

• 시장의 정의
• 목적
• 시장 범위
• 세분화
• 조사 방법

제2장 시장 요람

제3장 시장 개요

• 서론
  • 개요
    • 시장 구성과 시나리오
• 시장에 영향을 미치는 주요 요인
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장이 해결해야 할 과제
• Porter의 Five Forces 분석

제4장 세계 시장 : 장비 유형별

• 세계의 수동 IO 바늘 시장 : 지역별
• 세계의 배터리 구동형 드라이버 시장 : 지역별
• 세계의 임팩트 구동형 장비 시장 : 지역별

제5장 세계 시장 : 최종사용자별

• 세계의 병원 및 클리닉 시장 : 지역별
• 세계의 외래수술센터(ASC) 시장 : 지역별
• 세계의 기타 시장 : 지역별

제6장 세계 시장 : 지역별

• 북미
  • 북미 시장 : 국가별
    • 미국
    • 캐나다
    • 멕시코
    • 기타 북미
• 유럽
  • 유럽 시장 : 국가별
    • 독일
    • 영국
    • 프랑스
    • 러시아
    • 스페인
    • 이탈리아
    • 기타 유럽
• 아시아태평양
  • 아시아태평양 시장 : 국가별
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 말레이시아
    • 기타 아시아태평양
• 라틴아메리카/중동 및 아프리카
  • 라틴아메리카/중동 및 아프리카 시장 : 국가별
    • 브라질
    • 아르헨티나
    • 아랍에미리트(UAE)
    • 사우디아라비아
    • 남아프리카공화국
    • 나이지리아
    • 기타 라틴아메리카/중동 및 아프리카

제7장 기업 개요

• Aero Healthcare AU Pty Ltd
• The Seaberg Company Inc(SAM Medical)
• Medax Srl
• PAVmed Inc
• Teleflex Incorporated
• Becton, Dickinson, and Company
• Biopsybell SR.L
• Cook Medical, Inc(Cook Group)
• Argon Medical Devices, Inc(Shandong Weigao Group Medical Polymer Company Limited)

제8장 골내 주입 기기 시장을 위한 성공 필수 조건

LSH

영문 목차

영문목차

The Global Intraosseous Infusion Devices Market size is expected to reach $1.4 billion by 2031, rising at a market growth of 5.9% CAGR during the forecast period.

Healthcare systems in Europe prioritize patient safety, quality of care, and technological innovation. Thus, there is growing recognition of the importance of intraosseous access as a critical tool for rapid vascular access in emergency and critical care settings. Consequently, the Europe region would acquire nearly 30% of the total market share by 2031. Also, Europe boasts a well-developed healthcare infrastructure characterized by advanced medical facilities, robust regulatory frameworks, and high standards of patient care.

In moments of medical crisis, time is of the essence. These devices circumvent delays associated with conventional intravenous access, ensuring healthcare practitioners can promptly administer crucial medications and fluids to stabilize patients. Moreover, the increasing prevalence of medical emergencies underscores the importance of robust emergency response protocols. These devices play a pivotal role in these protocols, providing healthcare teams with a versatile and effective means of vascular access in diverse clinical settings, including pre-hospital environments, emergency departments, and critical care units. Thus, these factors will assist in the growth of the market. Additionally, the utilization of these devices extends beyond traditional emergency settings, permeating critical care units, military operations, and ambulatory care settings. This diversification of usage underscores the versatility of these devices in delivering a spectrum of essential treatments, including medications, fluids, and blood products, across varied healthcare landscapes. Moreover, the rugged and unpredictable nature of military operations necessitates medical interventions that are adaptable and resilient. These devices have emerged as indispensable assets in military healthcare settings, enabling frontline medics to initiate life-saving treatments swiftly and effectively, even in austere environments or under combat conditions. Hence, these aspects will pose lucrative growth prospects for the market.

Moreover, The COVID-19 pandemic placed an unparalleled burden on healthcare systems, resulting in a surge in the need for emergency medical apparatus, such as these devices. Moreover, the pandemic prompted a shift towards pre-hospital and field medicine as healthcare systems adapt to the challenges of managing COVID-19 patients outside traditional hospital settings. These devices became essential tools for emergency medical services (EMS) personnel, military medics, and first responders providing frontline care in community settings, field hospitals, makeshift treatment centers, and mass vaccination sites, where access to advanced medical facilities may be limited. Hence, the COVID-19 pandemic positively impacted the market.

However, the initial investment required for procuring these devices can be substantial, posing a barrier to adoption for healthcare organizations operating under tight budget constraints. Furthermore, beyond initial procurement and training, ongoing maintenance and replacement of consumables constitute recurring expenses associated with these devices. Hence, these aspects can lead to a downturn in the market.

By Devices Type Analysis

Based on devices type, the market is segmented into manual IO needles, battery powered driver, and impact driven devices. In 2023, the battery powered driver segment garnered a 26% revenue share in the market. Battery-powered drivers represent a significant advancement in intraosseous infusion technology, offering automated and motorized mechanisms for rapid and controlled insertion of intraosseous needles into the bone marrow space. These devices utilize battery-powered motors and mechanisms to drive the needle into the bone with consistent force and precision, minimizing user variability and enhancing procedural efficiency.

By End User Analysis

On the basis of end-use, the market is divided into hospitals & clinics, ambulatory surgical centers, and others. In 2023, the ambulatory surgical centers segment witnessed a 28% revenue share in the market. Ambulatory surgical centers have emerged as popular alternatives to traditional hospital-based care for various surgical procedures, including minor surgeries, diagnostic and therapeutic interventions, and emergency procedures. The convenience, efficiency, and cost-effectiveness of ASCs make them attractive options for patients seeking same-day procedures or short-stay surgical care.

By Regional Analysis

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured 40% revenue share in the market in 2023. North America, particularly the United States, faces a high burden of traumatic injuries, emergencies, and acute medical conditions, driving the demand for rapid and reliable vascular access solutions. These devices offer a valuable alternative for obtaining vascular access in critically ill or injured patients when traditional venous access is challenging or unattainable.

List of Key Companies Profiled

• Aero Healthcare AU Pty Ltd
• Teleflex Incorporated
• Becton, Dickinson and Company
• BIOPSYBELL S.R.L.
• Cook Medical, Inc.(Cook Group)
• The Seaberg Company Inc. (SAM Medical)
• Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
• Medax Srl
• PAVmed Inc.

Global Intraosseous Infusion Devices Market Report Segmentation

By Devices Type

• Manual IO Needles
• Battery Powered Driver
• Impact Driven Devices

By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Intraosseous Infusion Devices Market, by Devices Type
  • 1.4.2Global Intraosseous Infusion Devices Market, by End User
  • 1.4.3Global Intraosseous Infusion Devices Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Restraints
  • 3.2.3Market Opportunities
  • 3.2.4Market Challenges
• 3.3Porter Five Forces Analysis

Chapter 4.Global Intraosseous Infusion Devices Market by Devices Type

• 4.1Global Manual IO Needles Market by Region
• 4.2Global Battery Powered Driver Market by Region
• 4.3Global Impact Driven Devices Market by Region

Chapter 5.Global Intraosseous Infusion Devices Market by End User

• 5.1Global Hospitals & Clinics Market by Region
• 5.2Global Ambulatory Surgical Centers Market by Region
• 5.3Global Others Market by Region

Chapter 6.Global Intraosseous Infusion Devices Market by Region

• 6.1North America Intraosseous Infusion Devices Market
  • 6.1.1North America Intraosseous Infusion Devices Market by Devices Type
    • 6.1.1.1North America Manual IO Needles Market by Country
    • 6.1.1.2North America Battery Powered Driver Market by Country
    • 6.1.1.3North America Impact Driven Devices Market by Country
  • 6.1.2North America Intraosseous Infusion Devices Market by End User
    • 6.1.2.1North America Hospitals & Clinics Market by Country
    • 6.1.2.2North America Ambulatory Surgical Centers Market by Country
    • 6.1.2.3North America Others Market by Country
  • 6.1.3North America Intraosseous Infusion Devices Market by Country
    • 6.1.3.1US Intraosseous Infusion Devices Market
      • 6.1.3.1.1US Intraosseous Infusion Devices Market by Devices Type
      • 6.1.3.1.2US Intraosseous Infusion Devices Market by End User
    • 6.1.3.2Canada Intraosseous Infusion Devices Market
      • 6.1.3.2.1Canada Intraosseous Infusion Devices Market by Devices Type
      • 6.1.3.2.2Canada Intraosseous Infusion Devices Market by End User
    • 6.1.3.3Mexico Intraosseous Infusion Devices Market
      • 6.1.3.3.1Mexico Intraosseous Infusion Devices Market by Devices Type
      • 6.1.3.3.2Mexico Intraosseous Infusion Devices Market by End User
    • 6.1.3.4Rest of North America Intraosseous Infusion Devices Market
      • 6.1.3.4.1Rest of North America Intraosseous Infusion Devices Market by Devices Type
      • 6.1.3.4.2Rest of North America Intraosseous Infusion Devices Market by End User
• 6.2Europe Intraosseous Infusion Devices Market
  • 6.2.1Europe Intraosseous Infusion Devices Market by Devices Type
    • 6.2.1.1Europe Manual IO Needles Market by Country
    • 6.2.1.2Europe Battery Powered Driver Market by Country
    • 6.2.1.3Europe Impact Driven Devices Market by Country
  • 6.2.2Europe Intraosseous Infusion Devices Market by End User
    • 6.2.2.1Europe Hospitals & Clinics Market by Country
    • 6.2.2.2Europe Ambulatory Surgical Centers Market by Country
    • 6.2.2.3Europe Others Market by Country
  • 6.2.3Europe Intraosseous Infusion Devices Market by Country
    • 6.2.3.1Germany Intraosseous Infusion Devices Market
      • 6.2.3.1.1Germany Intraosseous Infusion Devices Market by Devices Type
      • 6.2.3.1.2Germany Intraosseous Infusion Devices Market by End User
    • 6.2.3.2UK Intraosseous Infusion Devices Market
      • 6.2.3.2.1UK Intraosseous Infusion Devices Market by Devices Type
      • 6.2.3.2.2UK Intraosseous Infusion Devices Market by End User
    • 6.2.3.3France Intraosseous Infusion Devices Market
      • 6.2.3.3.1France Intraosseous Infusion Devices Market by Devices Type
      • 6.2.3.3.2France Intraosseous Infusion Devices Market by End User
    • 6.2.3.4Russia Intraosseous Infusion Devices Market
      • 6.2.3.4.1Russia Intraosseous Infusion Devices Market by Devices Type
      • 6.2.3.4.2Russia Intraosseous Infusion Devices Market by End User
    • 6.2.3.5Spain Intraosseous Infusion Devices Market
      • 6.2.3.5.1Spain Intraosseous Infusion Devices Market by Devices Type
      • 6.2.3.5.2Spain Intraosseous Infusion Devices Market by End User
    • 6.2.3.6Italy Intraosseous Infusion Devices Market
      • 6.2.3.6.1Italy Intraosseous Infusion Devices Market by Devices Type
      • 6.2.3.6.2Italy Intraosseous Infusion Devices Market by End User
    • 6.2.3.7Rest of Europe Intraosseous Infusion Devices Market
      • 6.2.3.7.1Rest of Europe Intraosseous Infusion Devices Market by Devices Type
      • 6.2.3.7.2Rest of Europe Intraosseous Infusion Devices Market by End User
• 6.3Asia Pacific Intraosseous Infusion Devices Market
  • 6.3.1Asia Pacific Intraosseous Infusion Devices Market by Devices Type
    • 6.3.1.1Asia Pacific Manual IO Needles Market by Country
    • 6.3.1.2Asia Pacific Battery Powered Driver Market by Country
    • 6.3.1.3Asia Pacific Impact Driven Devices Market by Country
  • 6.3.2Asia Pacific Intraosseous Infusion Devices Market by End User
    • 6.3.2.1Asia Pacific Hospitals & Clinics Market by Country
    • 6.3.2.2Asia Pacific Ambulatory Surgical Centers Market by Country
    • 6.3.2.3Asia Pacific Others Market by Country
  • 6.3.3Asia Pacific Intraosseous Infusion Devices Market by Country
    • 6.3.3.1China Intraosseous Infusion Devices Market
      • 6.3.3.1.1China Intraosseous Infusion Devices Market by Devices Type
      • 6.3.3.1.2China Intraosseous Infusion Devices Market by End User
    • 6.3.3.2Japan Intraosseous Infusion Devices Market
      • 6.3.3.2.1Japan Intraosseous Infusion Devices Market by Devices Type
      • 6.3.3.2.2Japan Intraosseous Infusion Devices Market by End User
    • 6.3.3.3India Intraosseous Infusion Devices Market
      • 6.3.3.3.1India Intraosseous Infusion Devices Market by Devices Type
      • 6.3.3.3.2India Intraosseous Infusion Devices Market by End User
    • 6.3.3.4South Korea Intraosseous Infusion Devices Market
      • 6.3.3.4.1South Korea Intraosseous Infusion Devices Market by Devices Type
      • 6.3.3.4.2South Korea Intraosseous Infusion Devices Market by End User
    • 6.3.3.5Australia Intraosseous Infusion Devices Market
      • 6.3.3.5.1Australia Intraosseous Infusion Devices Market by Devices Type
      • 6.3.3.5.2Australia Intraosseous Infusion Devices Market by End User
    • 6.3.3.6Malaysia Intraosseous Infusion Devices Market
      • 6.3.3.6.1Malaysia Intraosseous Infusion Devices Market by Devices Type
      • 6.3.3.6.2Malaysia Intraosseous Infusion Devices Market by End User
    • 6.3.3.7Rest of Asia Pacific Intraosseous Infusion Devices Market
      • 6.3.3.7.1Rest of Asia Pacific Intraosseous Infusion Devices Market by Devices Type
      • 6.3.3.7.2Rest of Asia Pacific Intraosseous Infusion Devices Market by End User
• 6.4LAMEA Intraosseous Infusion Devices Market
  • 6.4.1LAMEA Intraosseous Infusion Devices Market by Devices Type
    • 6.4.1.1LAMEA Manual IO Needles Market by Country
    • 6.4.1.2LAMEA Battery Powered Driver Market by Country
    • 6.4.1.3LAMEA Impact Driven Devices Market by Country
  • 6.4.2LAMEA Intraosseous Infusion Devices Market by End User
    • 6.4.2.1LAMEA Hospitals & Clinics Market by Country
    • 6.4.2.2LAMEA Ambulatory Surgical Centers Market by Country
    • 6.4.2.3LAMEA Others Market by Country
  • 6.4.3LAMEA Intraosseous Infusion Devices Market by Country
    • 6.4.3.1Brazil Intraosseous Infusion Devices Market
      • 6.4.3.1.1Brazil Intraosseous Infusion Devices Market by Devices Type
      • 6.4.3.1.2Brazil Intraosseous Infusion Devices Market by End User
    • 6.4.3.2Argentina Intraosseous Infusion Devices Market
      • 6.4.3.2.1Argentina Intraosseous Infusion Devices Market by Devices Type
      • 6.4.3.2.2Argentina Intraosseous Infusion Devices Market by End User
    • 6.4.3.3UAE Intraosseous Infusion Devices Market
      • 6.4.3.3.1UAE Intraosseous Infusion Devices Market by Devices Type
      • 6.4.3.3.2UAE Intraosseous Infusion Devices Market by End User
    • 6.4.3.4Saudi Arabia Intraosseous Infusion Devices Market
      • 6.4.3.4.1Saudi Arabia Intraosseous Infusion Devices Market by Devices Type
      • 6.4.3.4.2Saudi Arabia Intraosseous Infusion Devices Market by End User
    • 6.4.3.5South Africa Intraosseous Infusion Devices Market
      • 6.4.3.5.1South Africa Intraosseous Infusion Devices Market by Devices Type
      • 6.4.3.5.2South Africa Intraosseous Infusion Devices Market by End User
    • 6.4.3.6Nigeria Intraosseous Infusion Devices Market
      • 6.4.3.6.1Nigeria Intraosseous Infusion Devices Market by Devices Type
      • 6.4.3.6.2Nigeria Intraosseous Infusion Devices Market by End User
    • 6.4.3.7Rest of LAMEA Intraosseous Infusion Devices Market
      • 6.4.3.7.1Rest of LAMEA Intraosseous Infusion Devices Market by Devices Type
      • 6.4.3.7.2Rest of LAMEA Intraosseous Infusion Devices Market by End User

Chapter 7.Company Profiles

• 7.1Aero Healthcare AU Pty Ltd
  • 7.1.1Company Overview
• 7.2The Seaberg Company Inc. (SAM Medical)
  • 7.2.1Company Overview
  • 7.2.2Recent strategies and developments:
    • 7.2.2.1Product Launches and Product Expansions:
• 7.3Medax Srl
  • 7.3.1Company Overview
• 7.4PAVmed Inc.
  • 7.4.1Company Overview
  • 7.4.2Financial Analysis
• 7.5Teleflex Incorporated
  • 7.5.1Company Overview
  • 7.5.2Financial Analysis
  • 7.5.3Segmental and Regional Analysis
  • 7.5.4Research & Development Expenses
  • 7.5.5Recent strategies and developments:
    • 7.5.5.1Trials and Approvals:
  • 7.5.6SWOT Analysis
• 7.6Becton, Dickinson, and Company
  • 7.6.1Company Overview
  • 7.6.2Financial Analysis
  • 7.6.3Segmental and Regional Analysis
  • 7.6.4Research & Development Expense
  • 7.6.5SWOT Analysis
• 7.7Biopsybell S.R.L.
  • 7.7.1Company Overview
• 7.8Cook Medical, Inc. (Cook Group)
  • 7.8.1Company Overview
  • 7.8.2SWOT Analysis
• 7.9Argon Medical Devices, Inc. (Shandong Weigao Group Medical Polymer Company Limited)
  • 7.9.1Company Overview
  • 7.9.2Financial Analysis

Chapter 8.Winning Imperatives for Intraosseous Infusion Devices Market

관련자료